The 2011 Crossing Wall Street Buy List

*Drumroll please*

Ladies and gentlemen, the following 20 stocks are my Buy List for 2011:

Abbott Laboratories (ABT)
Becton, Dickinson & Co. (BDX)
Bed Bath & Beyond (BBBY)
Deluxe Corp. (DLX)
Fiserv (FISV)
Ford Motor Company (F)
Gilead Sciences (GILD)
Johnson & Johnson (JNJ)
Jos. A Bank Clothiers (JOSB)
JPMorgan Chase (JPM)
Leucadia National (LUK)
Medtronic (MDT)
Moog (MOG-A)
Nicholas Financial (NICK)
Oracle (ORCL)
Reynolds American (RAI)
Stryker (SYK)
Sysco (SYY)
Wright Express (WXS)

The five new stocks are Abbott Laboratories (ABT), Deluxe Corp. (DLX), Ford (F), Oracle (ORCL) and JPMorgan Chase (JPM).

The five stocks I’m deleting are Baxter International (BAX), Eaton Vance (EV), Eli Lilly (LLY), Intel (INTC) and SEI Investments (SEIC).

This change doesn’t mean I think the old stocks are about to collapse. I simply believe the new stocks are better opportunities.

The new Buy List goes into effect at the start of trading on Monday, January 3, 2011 which is the first trading day of the new year.

I will track the Buy List as if it is a $1 million portfolio with 20 equally-weighted positions of $50,000 each based on the closing price on December 31, 2010.

My normal rule is that I can’t make any changes to the Buy List during the entire year.

The biggest stock is Johnson & Johnson with a market cap of $171 billion. The smallest is Nicholas Financial with a market cap of just $120 million. Combined, the 20 stocks are worth $820 billion.

Twelve of the 20 stocks pay a dividend, and if no stock raises or lowers its dividend for the next twelve months, the dividend yield for the entire Buy List will be 1.56%. The Buy List is trading at just 11.6 times next year’s earnings.

Posted by on December 17th, 2010 at 11:03 am

The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.